The FDA approved Moderna's mFlusiva in August, and it's now available to adults 50 and older.
A new mRNA flu vaccine promises a closer match to circulating flu strains. But dysfunction at federal health agencies is ...
Share on Pinterest Subtle differences in immune system reactions may explain why some people get more serious side effects ...
A new mRNA flu vaccine offering stronger protection against influenza could soon become available in Canada as Health Canada ...
For some older adults, the flu vaccine could look a little different this year. In August, the US Food and Drug Administration approved the nation’s first mRNA-based flu vaccine for use in people 50 ...
As millions of people know firsthand, the most common side effect of mRNA vaccines like the COVID-19 shot is inflammation: soreness, redness and a day or two of malaise. But what if mRNA vaccines ...
More than 13 billion doses of mRNA vaccines have been administered globally since the rollout in the United States of COVID-19 shots in December 2020 via Operation Warp Speed under the first Trump ...
Localized rectal delivery of IL-35 mRNA to inflamed intestinal lesions using lipid nanoparticles made from a steroid backbone ...
Postdoctoral fellow and co-first author Dongyoon Kim demonstrates some of the equipment used to craft the new ionizable lipids. [Bella Ciervo, Penn Engineering] The explosion of mRNA vaccines brought ...
mRNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the blueprint for functional proteins into the body so that induces therapeutic ...
Moderna's mRNA flu vaccine just cleared its biggest hurdle. On Wednesday, the FDA approved mFlusiva (formerly known as mRNA-1010) for adults 50 and older, marking the first mRNA-based flu shot ever ...
Health experts are talking about the new mRNA flu vaccine after it was approved by the FDA for adults over 50.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results